Inhaler: peak plasma concentrations of 49ng/mL reached within 15 minutes. Nasal spray: maximum venous concentrations of 2–12ng/mL reached in 4–15 minutes. Nasal Spray antagonized by nasal ...

Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good afternoon! Inhalers ...

A recent tweak to a Medicaid formula could be behind the shakeup to inhaler products, a series of changes which have both benefited and harmed patients with asthma and chronic obstructive pulmonary ...

estimates that a 5 to 10 percent “uplift” in overall inhaler sales from new green versions could increase yearly revenue by close to $100 million. “We are talking about big-name products ...

GSK has developed a new propellant technology for inhaler devices that drastically ... is ready to start phase 3 testing in GSK’s asthma product Ventolin (salbutamol) next year, and according ...

Are you a print subscriber? Activate your account. By Garett Sloane - 2 hours 35 min ago By Gillian Follett - 2 hours 35 min ago By E.J. Schultz - 2 hours 35 min ago By Jack Neff - 2 hours 35 min ...

Merck & Co., Inc. is a health care company ... animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other.

Members of the HELP Committee are criticizing drugmakers for charging more for inhalers in the U.S. than in other countries. Improving the Patient Financial Experience Throughout the Patient Journey ...

Boehringer Ingelheim is the latest company in respiratory health to announce a collaboration to create a 'smart' version of an inhaler product. Boehringer Ingelheim (BI) is to work with ...

Merck (MRK) is set to announce Q3 earnings on October 31st. Analysts expect a profit of $1.57 per share on revenue of $16.51B ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.